Transient Depletion of Pre-Existing Antibodies for Efficient AAV Gene Delivery Treating MPS IIIA in Mice

被引：0
|
作者：
Fu, Haiyan [1 ]
Samowitz, Preston [1 ]
Robinson, Michael [1 ]
Forsberg, John [1 ]
Feng, Richard [1 ]
Nicely, Nathan [1 ]
Bobo, Tierra [1 ]
机构：
[1] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
270
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [21] Pre-existing Anti-AAV9 antibodies in the Chinese healthy and rare disease populations: Implications for gene therapy
    Zhao, Qian
    Yu, Shuangqing
    Fu, Diyi
    Wu, Zhen
    Zhou, Jianfang
    Yang, Yi
    Chen, Chen
    Wu, Ni
    Wang, Yucan
    Xi, Wanlin
    Lou, Ning
    Wu, Xiaobing
    Han, Xiaohong
    VIRUS RESEARCH, 2025, 354
  • [22] Global seroprevalence of pre-existing antibodies against various AAV serotypes in hemophilia A adults and adolescents
    Hayes, Gregory M.
    Andrea, Tatiana
    Klamroth, Robert
    Hardesty, Brandon
    Suzuki, Takashi
    Stieltjes, Natalie
    Peyvandi, Flora
    Oldenburg, Johannes
    Shima, Midori
    Mahlangu, Johnny
    Ozelo, Margareth Castro
    Wong, Wing Yen
    HAEMOPHILIA, 2020, 26 : 20 - 21
  • [23] Optimizing IdeS treatment regimen for enhanced AAV transduction in individuals with pre-existing anti-AAV neutralizing antibodies
    Ros-Ganan, I.
    Hommel, M.
    Trigueros-Motos, L.
    Tamarit, B.
    Rodriguez-Garcia, E.
    Salas, D.
    Douar, A.
    Combal, J. P.
    Benichou, B.
    Ferrer, V.
    Gonzalez-Aseguinolaza, G.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A29 - A29
  • [24] Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
    Fitzpatrick, Zachary
    Leborgne, Christian
    Barbon, Elena
    Masat, Elisa
    Ronzitti, Giuseppe
    van Wittenberghe, Laetitia
    Vignaud, Alban
    Collaud, Fanny
    Charles, Severine
    Sola, Marcelo Simon
    Jouen, Fabienne
    Boyer, Olivier
    Mingozzi, Federico
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2018, 9 : 119 - 129
  • [25] Pre-Existing Neutralizing Antibodies to AAV2 and AAV5 in the Serum and Synovial Fluid of 20 Horses
    Ortved, Kyla F.
    Calcedo, Roberto
    Nixon, Alan J.
    MOLECULAR THERAPY, 2012, 20 : S48 - S48
  • [26] A Novel Gene Delivery Vector with Low Pre-Existing Immunity in Humans
    Nawandar, Dhananjay
    Timpona, Joseph
    Boisvert, Nicole
    Diaz, Fernando
    Lebo, Kevin
    Thurmond, Stephanie
    Bounoutas, George
    Mackey, Ashley
    Thakker, Parmi
    Fusco, Robert
    Hajjar, Roger
    Weistein, Erica
    Echelard, Yann
    Ong, Tuyen
    Chang, Yong
    Kahvejian, Avak
    Delagrave, Simon
    MOLECULAR THERAPY, 2022, 30 (04) : 538 - 538
  • [27] Enhanced Liver Transduction and Efficient Protection from Pre-Existing Neutralizing Antibodies with Exosome-Associated AAV8 Vectors
    Meliani, Amine
    Fitzpatrick, Zachary
    Boisgerault, Florence
    Ronzitti, Giuseppe
    Collaud, Fanny
    Charles, Severine
    Maguire, Casey A.
    Mingozzi, Federico
    MOLECULAR THERAPY, 2016, 24 : S235 - S236
  • [28] Depletion of Pre-Existing Anti-AAV Neutralizing Antibodies by a Combination Immunosuppressive Treatment with Bortezomib and CD20 mAb Allows Successful Vector Re-Administration in Mice
    Choi, Su Jin
    Yi, John
    Tedder, Thomas F.
    Koeberl, Dwight D.
    Kishnani, Priya S.
    Sun, Baodong
    MOLECULAR THERAPY, 2021, 29 (04) : 361 - 361
  • [29] AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9
    Li, Ang
    Tanner, Mark R.
    Lee, Ciaran M.
    Hurley, Ayrea E.
    De Giorgi, Marco
    Jarrett, Kelsey E.
    Davis, Timothy H.
    Doerfler, Alexandria M.
    Bao, Gang
    Beeton, Christine
    Lagor, William R.
    MOLECULAR THERAPY, 2020, 28 (06) : 1432 - 1441
  • [30] AAV-CRISPR Gene Editing is Negated by Pre-Existing Immunity to Cas9
    Li, Ang
    Lee, Ciaran M.
    Tanner, Mark R.
    Hurley, Ayrea E.
    De Giorgi, Marco
    Jarrett, Kelsey E.
    Davis, Timothy H.
    Doerfler, Alexandria M.
    Bao, Gang
    Beeton, Christine
    Lagor, William R.
    MOLECULAR THERAPY, 2020, 28 (04) : 565 - 566
12345